Spots Global Cancer Trial Database for stage ii grade 1 follicular lymphoma
Every month we try and update this database with for stage ii grade 1 follicular lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma | NCT00553501 | Lymphoma | epratuzumab rituximab | 18 Years - | Alliance for Clinical Trials in Oncology | |
Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma | NCT00553501 | Lymphoma | epratuzumab rituximab | 18 Years - | Alliance for Clinical Trials in Oncology | |
Gazyvaro and Low Dose Radiotherapy in Early Stage Follicular Lymphoma | NCT03341520 | Stage II Grade ... Stage II Grade ... Stage I Follicu... Stage II Follic... | Obinutuzumab In... Low dose radiat... | 18 Years - | Heidelberg University | |
GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma | NCT00893477 | Lymphoma | rituximab sargramostim gene expression... gene rearrangem... polymerase chai... polymorphism an... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma | NCT00553501 | Lymphoma | epratuzumab rituximab | 18 Years - | Alliance for Clinical Trials in Oncology | |
SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant | NCT00002657 | Lymphoma Multiple Myelom... | bleomycin sulfa... recombinant int... cyclophosphamid... cytarabine doxorubicin hyd... etoposide methotrexate prednisone vincristine sul... conventional su... radiation thera... | 15 Years - | SWOG Cancer Research Network |